Literature DB >> 15249042

Protein aggregation during overexpression limited by peptide extensions with large net negative charge.

Yian-Biao Zhang1, Jason Howitt, Sean McCorkle, Paul Lawrence, Karen Springer, Paul Freimuth.   

Abstract

Folding of the human coxsackie and adenovirus receptor immunoglobulin (Ig) variable-type domain (CAR D1) during overexpression in the Escherichia coli cytoplasm was shown previously to be partially rescued by fusion to a 22-residue C-terminal peptide. Here, peptide sequence features required for solubilization and folding of CAR D1 and similar Ig variable-type domains from two other human membrane proteins were investigated. Peptide extensions with net negative charge > -6 fully solubilized CAR D1, and approximately half of the peptide-solubilized protein was correctly folded. The Ig variable-type domains from human A33 antigen and myelin P-zero proteins were only partially solubilized by peptide extensions with net charge of -12, however, and only the solubilized P-zero domain appeared to fold correctly whereas the A33 domain formed soluble microaggregates of misfolded protein. Our results suggest a model where the large net charge of peptide extensions increases electrostatic repulsion between nascent polypeptides. The resulting decrease in aggregation rate can enable some polypeptides to fold spontaneously into their native protein conformations. Analysis of the solubility and folding status of sets of structurally homologous proteins, such as the Ig variable-type domains described here, during overexpression could provide insights into how amino acid and gene sequences influence the efficiency of spontaneous protein folding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249042     DOI: 10.1016/j.pep.2004.04.020

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  40 in total

1.  Combinatorial method for overexpression of membrane proteins in Escherichia coli.

Authors:  Shani Leviatan; Keisuke Sawada; Yoshinori Moriyama; Nathan Nelson
Journal:  J Biol Chem       Date:  2010-06-04       Impact factor: 5.157

2.  Recombinant botulinum neurotoxin A heavy chain-based delivery vehicles for neuronal cell targeting.

Authors:  Mengfei Ho; Li-Hsin Chang; Melissa Pires-Alves; Baskaran Thyagarajan; Jordan E Bloom; Zhengrong Gu; Karla K Aberle; Sasha A Teymorian; Yuka Bannai; Steven C Johnson; Joseph J McArdle; Brenda A Wilson
Journal:  Protein Eng Des Sel       Date:  2010-11-04       Impact factor: 1.650

3.  Electrostatic engineering of the interface between heavy and light chains promotes antibody Fab fragment production.

Authors:  Yuki Ohmuro-Matsuyama; Keita Mori; Hirotsugu Hamada; Hiroshi Ueda; Hideki Yamaji
Journal:  Cytotechnology       Date:  2016-02-08       Impact factor: 2.058

Review 4.  Protein aggregation and bioprocessing.

Authors:  Mary E M Cromwell; Eric Hilario; Fred Jacobson
Journal:  AAPS J       Date:  2006-09-15       Impact factor: 4.009

5.  N-terminal domains of native multidomain proteins have the potential to assist de novo folding of their downstream domains in vivo by acting as solubility enhancers.

Authors:  Chul Woo Kim; Kyoung Sim Han; Ki-Sun Ryu; Byung Hee Kim; Kyun-Hwan Kim; Seong Il Choi; Baik L Seong
Journal:  Protein Sci       Date:  2007-04       Impact factor: 6.725

6.  Mutations that alter the equilibrium between open and closed conformations of Escherichia coli maltose-binding protein impede its ability to enhance the solubility of passenger proteins.

Authors:  Sreedevi Nallamsetty; David S Waugh
Journal:  Biochem Biophys Res Commun       Date:  2007-10-22       Impact factor: 3.575

7.  Enhancing the stability and solubility of TEV protease using in silico design.

Authors:  Lisa D Cabrita; Dimitri Gilis; Amy L Robertson; Yves Dehouck; Marianne Rooman; Stephen P Bottomley
Journal:  Protein Sci       Date:  2007-09-28       Impact factor: 6.725

8.  IgG Aggregation Mechanism for CHO Cell Lines Expressing Excess Heavy Chains.

Authors:  Steven C L Ho; Tianhua Wang; Zhiwei Song; Yuansheng Yang
Journal:  Mol Biotechnol       Date:  2015-07       Impact factor: 2.695

9.  Aggregation and chemical modification of monoclonal antibodies under upstream processing conditions.

Authors:  Stefan Dengl; Marc Wehmer; Friederike Hesse; Florian Lipsmeier; Oliver Popp; Kurt Lang
Journal:  Pharm Res       Date:  2013-01-16       Impact factor: 4.200

10.  Mocr: a novel fusion tag for enhancing solubility that is compatible with structural biology applications.

Authors:  James DelProposto; Chinmay Y Majmudar; Janet L Smith; William Clay Brown
Journal:  Protein Expr Purif       Date:  2008-09-12       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.